NCT04403503View on ClinicalTrials.gov

The Influence of Tissue Adhesive to Palatal Donor Site Healing.

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

February 1, 2019

Study Completion Date

March 1, 2019

Conditions
Donor Site Complication
Interventions
DRUG

Gelatin Sponge;Thrombin, Bovine 5000 IU Multiple Routes Kit [GELFOAM-JMI SPONGE KIT]

Donor site was closed either with GS (Spongostan®, Ethicon, Somerville, USA) (GS group)

DRUG

Cyanoacrylate, Isobutyl

Donor site was closed either with GS (Spongostan®, Ethicon, Somerville, USA) (GS group) and GS covered with high viscosity CY (PeriAcryl®, Glustitch Inc., Delta, Canada) (GS+CY group).

Trial Locations (1)

06100

Hacettepe University, Ankara

All Listed Sponsors
lead

Hacettepe University

OTHER

NCT04403503 - The Influence of Tissue Adhesive to Palatal Donor Site Healing. | Biotech Hunter | Biotech Hunter